Market Research Logo

Global Pharmaceutical Contract Manufacturing Market 2016-2020

Global Pharmaceutical Contract Manufacturing Market 2016-2020

About Pharmaceutical Contract Manufacturing

Contract manufacturing involves outsourcing manufacturing products to organizations, which helps the organizations offer the same services at a relatively lower cost. Typically, in the pharmaceutical and biotechnology sectors, the sourcing companies seek contract manufacturing services to restructure their resource deployment toward high skill areas such as R&D and marketing. Contract manufacturing has potential growth opportunities in emerging countries such as India and China.

Technavio’s analysts forecast the global pharmaceutical contract manufacturing market to grow at a CAGR of 6.91% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global pharmaceutical contract manufacturing market for 2016-2020. To calculate the market size, the report considers the revenue generated from various pharmaceutical drug manufacturing outsourcing activities.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Pharmaceutical Contract Manufacturing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Catalent
  • Lonza
  • Pfizer CentreOne
Other prominent vendors
  • Abbott
  • Aenova
  • Amgen
  • Apotex
  • Aspen
  • AstraZeneca
  • Aurobindo Pharma
  • Baxter
  • BERLIN-CHEMIE
  • Biocon
  • Biogen
  • Boehringer Ingelheim
  • Celltrion
  • Cipla
  • Coherus Biosciences
  • Daiichi Sankyo
  • Dr. Reddy's Laboratories
  • Eli Lilly
  • Emcure Pharmaceuticals
  • Eurofarma Laboratories
  • Fareva
  • Gedeon Richter
  • Gilead Sciences
  • GlaxoSmithKline (GSK)
  • Hospira
  • Impax Laboratories
  • Intas Pharmaceuticals
  • Janssen Pharmaceuticals
  • Lupin
  • Merck
  • Mitsubishi Tanabe Pharma
  • Momenta Pharmaceuticals
  • Natco Pharma
  • Nexus Pharmaceuticals
  • Novo Nordisk
  • Orchid Chemicals & Pharmaceuticals
  • Par Pharmaceutical
  • Parenteral Drugs India
  • Patheon
  • Piramal
  • Roche Holding
  • Sanofi
  • Synthon
  • Teva Pharmaceuticals
  • Valeant Pharmaceuticals
  • Zentiva
  • Zhejiang Huahai Pharmaceutical
  • Zydus Cadila
Market driver
  • High number of US FDA-approved manufacturing facilities in emerging countries.
  • For a full, detailed list, view our report
Market challenge
  • Capacity utilization issues and lack of information integration.
  • For a full, detailed list, view our report
Market trend
  • Huge demand for next-generation biologics.
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Pharmaceutical Contract Manufacturing Market 2016-2020

Technavio recognizes the following companies as the key players in the global pharmaceutical contract manufacturing market: Catalent, Lonza, and Pfizer CentreOne.

Other prominent vendors in the market are: Abbott, Aenova, Amgen, Apotex, Aspen, AstraZeneca, Aurobindo Pharma, Baxter, BERLIN-CHEMIE, Biocon, Biogen, Boehringer Ingelheim, Celltrion, Cipla, Coherus Biosciences, Daiichi Sankyo, Dr. Reddy's Laboratories, Eli Lilly, Emcure Pharmaceuticals, Eurofarma Laboratories, Fareva, Gedeon Richter, Gilead Sciences, GlaxoSmithKline (GSK),Hospira, Impax Laboratories, Intas Pharmaceuticals, Janssen Pharmaceuticals, Lupin, Merck, Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Natco Pharma, Nexus Pharmaceuticals, Novo Nordisk, Orchid Chemicals & Pharmaceuticals, Par Pharmaceutical, Parenteral Drugs India, Patheon, Piramal, Roche Holding, Sanofi, Synthon, Teva Pharmaceuticals, Valeant Pharmaceuticals, Zentiva, Zhejiang Huahai Pharmaceutical, and Zydus Cadila.

Commenting on the report, an analyst from Technavio’s team said: “One of latest trends in the market is consolidation through vertical integration, alliances, and acquisitions. The major pharmaceutical companies have decreased their operations and R&D budgets, which has led to an increase in demand for outsourced services. Moreover, companies have consolidated their infrastructure in response to a sharp global economic downturn, poor revenue growth prospects, and expensive and inefficient operations. Strategic partnerships between pharmaceutical companies and CMOs have led to the reduction of government spending on manufacturing. The past few years have brought major changes to the pharmaceutical outsourcing services. As more in-house positions have been removed, pharmaceutical vendors are looking for strategic partnerships and 'one-stop' solutions.”

According to the report, one of the primary drivers in the market is high number of US FDA-approved manufacturing facilities in emerging countries. While selecting a partner for outsourcing, pharma companies look for the US FDA-approved plants along with skilled workforce and low operating costs. India, with more than 100 US FDA approved manufacturing facilities, is one of the most preferred locations for outsourcing manufacturing services. According to the research studies published in 2015, Indian suppliers accounted for around 25%-30% of the total drug master files (DMFs) filed with the US FDA. In addition, the implementation of the WTO TRIPS-mandated product patents (January 2005) has led to a rise in outsourcing in the developed markets.

Further, the report states that one major challenge in the market is lack of information integration. One of the greatest challenges faced by most vendors in the pharmaceutical contract manufacturing market is the lack of transparency and information integration in the whole supply chain process. Few medicines, especially vaccines and specialty injections, need fast delivery to ensure their utility. If companies are equipped with a centralized system, they will be able to observe changes in inventory and can order shipments as per requirements. Distribution vehicles or shipments can be redirected to obtain drugs in the required areas. With the right integration of available data from all the stages within the supply chain, companies can keep track of orders and delivery rates. This can effectively cure the delays and disruptions in the pharmaceutical supply chain, making the entire value chain effectively responsive to the unmet medical needs.



Companies Mentioned

Catalent, Lonza, Pfizer CentreOne, Abbott, Aenova, Amgen, Apotex, Aspen, AstraZeneca, Aurobindo Pharma, Baxter, BERLIN-CHEMIE, Biocon, Biogen, Boehringer Ingelheim, Celltrion, Cipla, Coherus Biosciences, Daiichi Sankyo, Dr. Reddy's Laboratories, Eli Lilly, Emcure Pharmaceuticals, Eurofarma Laboratories, Fareva, Gedeon Richter, Gilead Sciences, GlaxoSmithKline (GSK),Hospira, Impax Laboratories, Intas Pharmaceuticals, Janssen Pharmaceuticals, Lupin, Merck, Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Natco Pharma, Nexus Pharmaceuticals, Novo Nordisk, Orchid Chemicals & Pharmaceuticals, Par Pharmaceutical, Parenteral Drugs India, Patheon, Piramal, Roche Holding, Sanofi, Synthon, Teva Pharmaceuticals, Valeant Pharmaceuticals, Zentiva, Zhejiang Huahai Pharmaceutical, Zydus Cadila.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Service offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
      • Table Overview of global pharmaceutical contract manufacturing market
      • Table Global pharmaceutical contract manufacturing market: Present and future scenario
  • Pharmaceutical manufacturing outsourcing
    • Table Process of drug development
    • Table Value chain of pharmaceutical industry
    • Table Contract manufacturing market: Benefit analysis
    • Table Factors affecting pharmaceutical manufacturing outsourcing
    • Increased regulatory guidelines coupled with healthcare cost containment efforts
    • Rapid innovation and reduced product development lifecycle
    • High capital investment
      • Table Key factors and its impact on selection of CMOs
  • Market landscape
    • Market overview
      • Table Global pharmaceutical contract manufacturing market: Market overview
      • Table CMO market growth
      • Table Overview of outsourced new drug abbreviations (NDAs) in CMO industry
      • Table Cost comparison of drug development in the US and India
      • Table Global pharmaceutical contract manufacturing market 2015-2020 ($ billions)
      • Table Average number of services outsourced by company type 2013-2015
      • Table Preference for choosing pharmaceutical outsourcing partners
      • Table Factors affecting the global pharmaceutical contract manufacturing market
      • Table Opportunities analysis: Global pharmaceutical contract manufacturing market
      • Table Growth of global pharmaceutical contract manufacturing market 2016-2020
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by type of contract manufacturing
    • Table Market segmentation based on type of contract manufacturing
    • Table Segment outlook
    • Global API/bulk drug contract manufacturing market
      • Table Market overview of global API/bulk drug manufacturing market
      • Table Global API/bulk drug contract manufacturing market 2015-2020 ($ billions)
      • Table Global API/bulk drug contract manufacturing market
      • Table Overview of API outsourcing manufacturing market
    • Global FDF market
      • Table Market share of global FDF market 2015
      • Table Types of dosage forms
      • Table Lifecycle analysis of dosage formulations
      • Table Global FDF market 2015-2020 ($ billions)
      • Table Market share of global pharmaceutical contract manufacturing market 2015
  • Geographical segmentation
    • Global pharmaceutical contract manufacturing market by geography
      • Table Global pharmaceutical contract manufacturing market: Geography outlook 2015-2020
      • Table Global pharmaceutical contract manufacturing market: Current and future impact
    • Pharmaceutical contract manufacturing market in Americas
      • Table Pharmaceutical contract manufacturing market in Americas 2015-2020 ($ billions)
    • Pharmaceutical contract manufacturing market in APAC
      • Table Pharmaceutical contract manufacturing market in APAC 2015-2020 ($ billions)
    • Pharmaceutical contract manufacturing market in EMEA
      • Table Pharmaceutical contract manufacturing market in EMEA 2015-2020 ($ billions)
  • Key leading countries
    • Table Key leading countries
  • Market drivers
    • Table Impact of drivers and challenges on global pharmaceutical contract manufacturing market
    • Increased focus on core competence
      • Table Competitive advantage
      • Table Examples of global pharmaceutical companies sourcing from CMOs
    • High number of US FDA-approved manufacturing facilities in emerging countries
    • Shorter time-to-market
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Capacity utilization issues and lack of information integration
      • Table Capacity constraints by stage production 2015
    • Growing global competition
    • Lack of manufacturing standardization
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Table Impact of trends on global pharmaceutical contract manufacturing market
    • Consolidation through vertical integration, alliances, and acquisitions
      • Table Major M&A in global pharmaceutical contract manufacturing market
    • Huge demand for next-generation biologics
    • Value-added services
  • Vendor landscape
    • Competitive scenario
      • Table Key vendors: Geographical presence 2015
  • Key vendor analysis
    • Catalent
      • Table Catalent: Profile
      • Table Catalent: Metrics analysis
      • Table Catalent: Growth strategy matrix
      • Table Catalent: Opportunity assessment
    • Lonza
      • Table Lonza: Profile
      • Table Lonza: Metrics analysis
      • Table Lonza: Growth strategy matrix
      • Table Lonza: Opportunity assessment
    • Pfizer CentreOne
      • Table Pfizer CentreOne: Profile
      • Table Pfizer CentreOne profile: Metrics analysis
      • Table Pfizer CentreOne: Growth strategy matrix
      • Table Pfizer CentreOne: Growth opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report